Trinity Biotech plc
TRIB
$0.35
$0.000.91%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -31.79M | -20.33M | -32.20M |
| Total Depreciation and Amortization | -- | -- | 676.00K | 1.90M | 1.56M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 21.66M | 11.19M | 37.14M |
| Change in Net Operating Assets | -- | -- | 4.08M | -58.00K | -5.99M |
| Cash from Operations | -- | -- | -4.19M | -7.30M | 1.58M |
| Capital Expenditure | -- | -- | -405.00K | -498.00K | -1.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 0.00 | -- |
| Other Investing Activities | -- | -- | -22.56M | -20.63M | -6.12M |
| Cash from Investing | -- | -- | -22.97M | -21.12M | -7.32M |
| Total Debt Issued | -- | -- | 30.18M | 28.18M | 100.02M |
| Total Debt Repaid | -- | -- | -2.50M | -2.39M | -124.15M |
| Issuance of Common Stock | -- | -- | 7.66M | 7.12M | 25.02M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -6.52M | -7.66M | -15.38M |
| Cash from Financing | -- | -- | 28.81M | 25.24M | -14.50M |
| Foreign Exchange rate Adjustments | -- | -- | -175.00K | -240.00K | 17.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 1.48M | -3.42M | -20.22M |